Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/S090 stock hub

FRA/S090 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/S090is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

566.4M

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/S090FRA/S090

—

Loading chart…

In the news

Latest news · FRA/S090

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/S090 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

152

Groups with data

Currency

USD

Showing 152 of 152 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	137
Employees Change	-128%
Employees Change Percent	-41.83
Enterprise value	EUR 459.6M
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 566.4M
Price	EUR 32.8
Price currency	EUR
Rev Per Employee	637,121.34x
Sic	2836
Symbol	fra/S090
Website	https://www.sutrobio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-28.73%
EV Earnings	-2.82x
EV/FCF	-3.02x
EV/Sales	5.28x
FCF yield	-26.9%
P/B ratio	-5.02x
P/S ratio	6.49x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-102.41%
EBITDA Margin	-95.26%
Gross margin	-62.38%
Gross Profit	EUR -54.5M
Net Income	EUR -162.7M
Pretax Margin	-186.55%
Profit Margin	-186.45%
Profit Per Employee	EUR -1.2M
ROA	-23.38
Roa5y	-21.82
ROCE	-106.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	306.84%
Cagr3y	-11.42%
Cagr5y	-26.32%
Revenue Growth	65.18x
Revenue Growth Q	-21.35x
Revenue Growth3 Y	14.78x
Revenue Growth5 Y	19.12x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.37
Assets	EUR 148.1M
Cash	EUR 120.5M
Current Assets	EUR 128M
Current Liabilities	EUR 63.7M
Debt	EUR 13.3M
Debt FCF	EUR -0.09
Equity	EUR -112.8M
Interest Coverage	-2.5
Liabilities	EUR 260.9M
Long Term Assets	EUR 20.1M
Long Term Liabilities	EUR 197.2M
Net Cash	EUR 107.1M
Net Cash By Market Cap	EUR 18.91
Net Cash Growth	-57.19%
Tangible Book Value	EUR -112.8M
Tangible Book Value Per Share	EUR -13.14

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.01
Net Working Capital	EUR -49.3M
Quick ratio	1.94
Working Capital	EUR 64.6M
Working Capital Turnover	EUR 0.61

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-9.84%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	306.44%
200-day SMA	11.29
3Y total return	-30.51%
50-day SMA	20.44
50-day SMA vs 200-day SMA	50over200
5Y total return	-78.28%
All Time High	230
All Time High Change	-85.74%
All Time High Date	2021-01-25
All Time Low	4.66
All Time Low Change	604.16%
All Time Low Date	2025-04-22
ATR	1.66
Ch YTD	266.1
High	32.8
High52	32.8
High52 Date	2026-05-08
High52ch	0%
Low	32.2
Low52	5.58
Low52 Date	2025-07-02
Low52ch	488.34%
Ma50ch	60.5%
Price vs 200-day SMA	190.63%
RSI	73.72
RSI Monthly	58.29
RSI Weekly	83.67
Sharpe ratio	2.33x
Sortino ratio	4.67
Total Return	-9.84%
Tr YTD	266.1
Tr1m	60.78%
Tr3m	173.33%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -89.4M
Operating margin	-102.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13,307,348%
Shares Insiders	0.94%
Shares Institutions	30.5%
Shares Qo Q	2.91%
Shares Yo Y	9.84%
Short Ratio	3.5

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -164.3M
Average Volume	2x
Bv Per Share	-13.14
CAPEX	EUR -1.4M
Ch1m	60.78
Ch1y	306.4
Ch3m	173.3
Ch3y	-30.51
Ch5y	-78.28
Ch6m	327.9
Change	0%
Change From Open	1.86
Depreciation Amortization	6,210,473.7
Earnings Date	2026-03-27
EBIT	EUR -89.4M
EBITDA	EUR -83.1M
EPS	EUR -19.15
F Score	3
FCF	EUR -152.4M
FCF EV Yield	-33.16x
Financing CF	37,475
Fiscal Year End	December
Founded	2,003
Income Tax	EUR -79,208
Investing CF	38,337,572
Is Primary Listing	0
Last Report Date	2025-12-31
Last Split Date	2025-12-03
Last Split Type	Reverse
Ma150	12.69
Ma150ch	158.41%
Ma20	24.4
Ma20ch	34.43%
Net CF	-112,572,596
Open	32.2
Position In Range	100
Ppne	18,274,429.1
Price Date	2026-05-08
Relative Volume	20x
Revenue	87,285,623x
SBC By Revenue	13.67x
Share Based Comp	11,930,614
Tax By Revenue	-0.09x
Tr6m	327.92%
Z Score	-8.58

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/S090 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/S090 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/S090?

Insider, institutional, and short-interest positioning.

Institutional ownership

+30.5%

Share of float held by funds and institutions

Insider ownership

+0.9%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/S090 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

73.7

Above 70: short-term overbought

Price vs 200-day MA

+190.6%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

2.33

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/S090

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/S090 stock rating?

fra/S090 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/S090 analysis?

The full report lives at /stocks/fra/S090/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/S090?

The latest report frames fra/S090 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/S090 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.